MyAverix Finance
BK · Healthcare
Inter Pharma Public Company Limited (IP)
Biotechnology
Inter Pharma Public Company Limited (IP) is listed on BK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for IP
Inter Pharma Public Company Limited (IP) — FAQ
What is IP's P/E ratio?
The price-to-earnings (P/E) ratio for Inter Pharma Public Company Limited (IP) is 25.00 (data as of 2026-05-24).
Does Inter Pharma Public Company Limited pay a dividend?
Dividend yield is not available in the current snapshot for Inter Pharma Public Company Limited (IP). Check the MyAverix Finance app for the latest dividend data.
What sector is Inter Pharma Public Company Limited in?
Inter Pharma Public Company Limited (IP) is classified in the Healthcare sector (Biotechnology industry).
What exchange is IP listed on?
IP is listed on BK.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.